GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (LTS:0QLR) » Definitions » Change In Other Working Capital

Novartis AG (LTS:0QLR) Change In Other Working Capital : CHF401 Mil (TTM As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Novartis AG Change In Other Working Capital?

Novartis AG's Change In Other Working Capital for the quarter that ended in Mar. 2025 was CHF-537 Mil. It means Novartis AG's Other Working Capital declined by CHF537 Mil from Dec. 2024 to Mar. 2025 .

Novartis AG's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was CHF495 Mil. It means Novartis AG's Other Working Capital increased by CHF495 Mil from Dec. 2023 to Dec. 2024 .

Novartis AG Change In Other Working Capital Historical Data

The historical data trend for Novartis AG's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Change In Other Working Capital Chart

Novartis AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Other Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 390.01 453.13 318.61 1,039.49 494.84

Novartis AG Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -472.74 803.53 619.30 -484.14 -537.23

Novartis AG Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF401 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novartis AG Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Novartis AG's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Novartis AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (LTS:0QLR) » Definitions » Change In Other Working Capital
Comparable Companies
XSWX:ROG XSWX:COPN LLY JNJ ABBV OCSE:NOVO B LSE:AZN MRK AMGN PFE GILD XPAR:SAN BMY TSE:4519 LSE:GSK TSE:4568 SHSE:600276 XTER:BAYN TSE:4578 BIIB
Traded in Other Exchanges
NVSEF:USA NVS:USA NOVN:Mexico NVS N:Mexico NOVNz:UK 0K9E:UK NOT0:Germany NOTA:Germany NOTA:Germany NOVNEE:Switzerland NOVN:Switzerland NVS:Canada N1VS34:Brazil NVS:Argentina
Address
Lichtstrasse 35, Basel, CHE, 4056
Website
https://www.novartis.com
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

Novartis AG Headlines

No Headlines